Acetate vs TFA: peptide salt forms

Two vials labelled “BPC-157 5mg” can contain measurably different amounts of peptide. The difference is often the counter-ion — the acid left behind when the peptide is isolated as a salt.

Why a peptide is a salt, not a neutral molecule

Solid-phase synthesis ends with cleavage from the resin in strong acid, almost always trifluoroacetic acid. Purification by reversed-phase HPLC then runs in water/acetonitrile with TFA as the ion-pairing agent. When the purified fractions are frozen and dried, the peptide is left as a trifluoroacetate salt: the basic residues carry a positive charge and TFA provides the counter-ions.

Some suppliers stop there and ship the TFA salt. Others run an ion-exchange step to convert the material to acetate, which is the more common form for laboratory work. Both are legitimate; what matters is that the form is stated and that the specification matches it.

What the counter-ion changes

PropertyEffect of the salt formWhy it matters
Molecular weightEach TFA counter-ion adds about 114.02 Da; each acetate about 60.05 DaThe mass you measure by MS and the mass on the COA must refer to the same species
Peptide contentA 10 mg fill of a heavy salt contains less free peptide than the same fill of a light saltWeighing “10 mg” does not give 10 mg of peptide
Solution pHResidual TFA lowers the pH of the reconstituted solutionAssay buffers and pH-sensitive work can shift
Assay behaviourTFA is not inert in cell-based systems at higher concentrationsAn assay can be affected by the counter-ion rather than the peptide
HygroscopicitySalt form and residual moisture affect how quickly the powder takes up waterWeighing accuracy and stability during handling

Doing the arithmetic

Take a peptide with a free-base molecular weight of 1000.0 g/mol, supplied as a di-TFA salt. The salt mass is 1000.0 + (2 × 114.02) = 1228.04 g/mol, so 10 mg of powder contains 10 × (1000.0 / 1228.04) = 8.14 mg of free peptide. The same peptide as a di-acetate salt has a mass of 1000.0 + (2 × 60.05) = 1120.1 g/mol, and 10 mg of that powder contains 8.93 mg of free peptide.

That is roughly a 10% difference in the amount of peptide in the vial — enough to matter when you are preparing a stock solution to a target concentration, and enough to make two quotations incomparable if you only look at the nominal fill.

What a COA should state

Specification clauses worth adding

Name the form in the specification annex, not just in the product title. Require that the batch COA state the form and the peptide content, and require a maximum for residual TFA if your work is sensitive to it. If you are switching suppliers and the new material is a different salt, treat it as a new material: solubility, pH and assay behaviour may all shift, and a method transfer is a revalidation, not a formality.

Practical notes

Research use only. This article describes analytical and handling practice; it makes no claim about any specific compound and does not support administration to humans or animals.

Editor's take

Counter-ion content is invisible in a purity number and visible in your cost per milligram. Acetate and TFA are different materials with different masses; the label should say which.

Limitations

This guide describes methods and interpretation, not acceptance limits. Limits must come from your own specification and, where applicable, the relevant pharmacopoeial monograph. No testing was performed by the author for this page.

Products referenced in this guide

Related reading & products

💬 WhatsApp